Bethesda, Md., November 18, 2015 – The Parenteral Drug Association (PDA) has announced a change in leadership for its education programs.
Bob Dana, Sr. VP, Education has announced that he will retire at the end of 2015. Bob has been a long-term contributor to PDA in many ways, starting as a member, volunteer, and Board member, and, for the past ten years, as an employee—first as VP of Quality and Regulatory Affairs, and more recently as Sr. VP, Education. His commitment to PDA has been unwavering. Bob had over 30 years’ experience with industry prior to joining the staff. PDA wishes Bob all the best as he transitions to this new phase of his life.
Craig Elliott, Sr. VP, Finance/CFO, will assume the Sr. Vice President, Education role at the beginning of 2016. Craig has been at PDA more than six years in the CFO capacity, and this new challenge will give Craig the opportunity to expand his contributions to our organization, and to utilize his background in pharmaceutical manufacturing in a new way. Craig has a Bachelor’s degree in Microbiology and a Master’s in Business Administration. Prior to his 6 years with PDA, his career also includes 5 years at Merck & Co. in the QC & QA functions and 5 years with Genentech supporting the Operations, Quality & Regulatory Affairs functions.
PDA is in the process of identifying a candidate for the Finance position.
The Education activity is a key component of PDA’s future strategy, and our commitment to continue to invest and expand this function is clear. Craig and Bob began working together on this transition in September. PDA looks forward to Craig’s continued contributions to the organization in this new role.